Bionexus Gene Lab Corp (BGLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 752 | 662 | 367 | 339 | 1,094 |
| Depreciation Amortization | 108 | 82 | 55 | 15 | 102 |
| Accounts receivable | 579 | -199 | 109 | 403 | 411 |
| Accounts payable and accrued liabilities | -1,181 | -788 | -835 | -300 | -524 |
| Other Working Capital | -862 | -1,224 | -1,219 | -229 | 102 |
| Other Operating Activity | 613 | 993 | 733 | -113 | -632 |
| Operating Cash Flow | $9 | $-474 | $-790 | $115 | $553 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -2 | -2 | -1 | 1,046 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 346 |
| Purchase Of Investment | -516 | -432 | -372 | -296 | -109 |
| Sale Of Investment | 6 | 6 | 7 | N/A | 30 |
| Other Investing Activity | 22 | 14 | 11 | 1 | 6 |
| Investing Cash Flow | $-491 | $-414 | $-356 | $-296 | $1,320 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -26 | -21 | -15 | -9 | -5 |
| Other Financing Activity | -2 | -2 | -2 | 0 | 0 |
| Financing Cash Flow | $-28 | $-23 | $-17 | $-9 | $-5 |
| Exchange Rate Effect | -154 | -176 | -142 | -124 | 61 |
| Beginning Cash Position | 2,788 | 2,788 | 2,788 | 2,788 | 859 |
| End Cash Position | 2,124 | 1,700 | 1,483 | 2,475 | 2,788 |
| Net Cash Flow | $-664 | $-1,087 | $-1,305 | $-313 | $1,929 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9 | -474 | -790 | 115 | 553 |
| Capital Expenditure | -3 | -2 | -2 | -1 | -422 |
| Free Cash Flow | 6 | -476 | -791 | 115 | 131 |